Massachusetts Financial Services’s Tarsus Pharmaceuticals TARS Stock Holding History

Massachusetts Financial Services’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.9M	Buy	+427,008	New	+$27.3M	0.01%	611

Other funds holding TARS

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Massachusetts Financial Services's TARS Position: Q2 2026 in Review

Massachusetts Financial Services opened a new position in Tarsus Pharmaceuticals (TARS) in Q2 2026: 427,008 shares worth $26.9M. The stake represents 0.01% of the portfolio and ranks #611 among its holdings.

53 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

Massachusetts Financial Services held 427,008 shares of Tarsus Pharmaceuticals worth $26.9M as of Q2 2026.
Tarsus Pharmaceuticals was a new Massachusetts Financial Services position in Q2 2026.
Tarsus Pharmaceuticals made up 0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #611 holding.
53 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.